In a landmark move for India’s animal health sector, leading veterinary vaccine manufacturers have come together to form the Veterinary Vaccine India Manufacturers Association (VVIMA). The non-government, not-for-profit body aims to serve as the collective voice of India’s veterinary vaccine industry, collaborating with policymakers, regulators, and stakeholders to foster innovation, quality manufacturing, and global competitiveness.
The Indian veterinary vaccine market is estimated at INR 2,000 crore, while the global market exceeds INR 1 lakh crore. India produces vaccines for poultry, cattle, sheep, goats, swine, and pets, with eight private manufacturers and several state-owned units. VVIMA plans to align with the government’s Atmanirbhar Bharat vision, promoting self-reliance in animal vaccines through applied R&D, technology acquisition, and robust supply chains.
Industry leaders emphasized the role of VVIMA in advancing the One Health concept, safeguarding animal health, reducing zoonotic risks, and improving incomes for rural farmers engaged in animal husbandry. Founding members include Hester Biosciences, Indian Immuno logicals, Venkateshwara Hatcheries, and others. In Kolkata, veterinary vaccine demand is witnessing steady growth due to the city’s large poultry and livestock trade. Local distributors have welcomed VVIMA’s formation, anticipating improved access to high-quality vaccines, better pricing, and wider availability, which is expected to benefit livestock farmers and commercial poultry units across West Bengal.